Trademark: 79321390
Status Date
Tuesday, October 10, 2023
Registration Number
7184963
Registration Date
Tuesday, October 10, 2023
Filing Date
Friday, August 6, 2021
Published for Opposition
Tuesday, February 21, 2023
5 Pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the prevention of diseases of the endocrine system; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the prevention of diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for the prevention of disorders of the immune system; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for regulating the immune system; pharmaceutical products for the treatment of viral diseases; pharmaceutical preparations for urogenital organs; pharmaceutical preparations for preventing and treating obesity; pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for wounds; pharmaceutical preparations for activating cellular function; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; cardiovascular treatment preparations; pharmaceutical preparations for the prevention of disorders of the nervous system; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the prevention of inflammatory disorders; pharmaceutical preparations for the treatment of inflammatory diseases; antibacterial pharmaceuticals; pharmaceutical drugs being pharmaceutical preparations namely, for the treatment of autoimmune diseases, cardiovascular diseases and disorders, central nervous system diseases, inflammatory diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders; synthetic peptides for pharmaceutical purposes namely, for the treatment of autoimmune diseases, cardiovascular diseases and disorders, central nervous system diseases, inflammatory diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders; pharmaceutical compositions for the treatment of autoimmune diseases, cardiovascular diseases and disorders, central nervous system diseases, inflammatory diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders; clinical medical reagents; clinical diagnostic reagents for medicinal use; pharmaceutical preparations for the prevention of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for use in tissue transplantation; tissue-regenerative pharmaceutical preparations; pharmaceutical preparations for tumor treatment; stimulants for the central nervous system; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical products for treating respiratory diseases
42 Research and development of vaccines and medicines; research and development of technology for biotechnology; development of biotechnology; research relating to biotechnology; laboratory research in the field of biology; biological research services; development of new technologies in the field of biologics; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; research in the field of pharmacogenetics; development of pharmaceutical preparations and medicines; laboratory research in the field of pharmaceuticals; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; pharmaceutical drug development services; pharmaceutical research and development; research relating to pharmaceuticals; scientific research in the field of pharmacy; medical laboratory services; research relating to new technologies for medical treatment; medical research laboratory services; scientific research for medical purposes in the area of cancerous diseases; research and development of new technologies for others in the field of amino acid for medical purpose; research and development of new technologies for others in the field of peptide for medical purposes; research and development of technology for medicinal chemical manufacturing; medicine research; scientific research relating to medical substances; medical research; scientific research relating to chemistry
Jan 30, 2024
Final Decision Transaction Processed By Ib
Jan 10, 2024
Final Disposition Notice Sent To Ib
Jan 10, 2024
Final Disposition Processed
Jan 10, 2024
Final Disposition Notice Created, To Be Sent To Ib
Oct 10, 2023
Notice Of Registration Confirmation Emailed
Oct 10, 2023
Registered-Principal Register
Aug 31, 2023
Extension Of Time To Oppose Process - Terminated
Mar 20, 2023
Notification Of Possible Opposition - Processed By Ib
Mar 17, 2023
Extension Of Time To Oppose Received
Mar 1, 2023
Notification Of Possible Opposition Sent To Ib
Mar 1, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Feb 21, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 21, 2023
Published For Opposition
Feb 20, 2023
Notification Processed By Ib
Feb 1, 2023
Notification Of Possible Opposition Sent To Ib
Feb 1, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 1, 2023
Notification Of Notice Of Publication E-Mailed
Jan 18, 2023
Approved For Pub - Principal Register
Dec 15, 2022
Teas/Email Correspondence Entered
Dec 14, 2022
Correspondence Received In Law Office
Dec 14, 2022
Teas Response To Office Action Received
Oct 26, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 26, 2022
Teas Change Of Correspondence Received
Oct 26, 2022
Teas Change Of Domestic Representatives Address
Oct 26, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 26, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 26, 2022
Teas Change Of Owner Address Received
Jul 5, 2022
Refusal Processed By Ib
Jun 15, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jun 15, 2022
Refusal Processed By Mpu
May 13, 2022
Non-Final Action (Ib Refusal) Prepared For Review
May 12, 2022
Non-Final Action Written
May 6, 2022
Assigned To Examiner
Oct 9, 2021
Application Filing Receipt Mailed
Oct 5, 2021
New Application Office Supplied Data Entered
Sep 30, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
